chr10-3143430-T-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_014889.4(PITRM1):āc.2604A>Cā(p.Glu868Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00035 in 1,613,582 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014889.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000677 AC: 103AN: 152152Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.000301 AC: 75AN: 249162Hom.: 0 AF XY: 0.000296 AC XY: 40AN XY: 135176
GnomAD4 exome AF: 0.000315 AC: 461AN: 1461430Hom.: 0 Cov.: 30 AF XY: 0.000308 AC XY: 224AN XY: 727022
GnomAD4 genome AF: 0.000677 AC: 103AN: 152152Hom.: 4 Cov.: 33 AF XY: 0.000821 AC XY: 61AN XY: 74320
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | PITRM1: BP4, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 30, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 770 of the PITRM1 protein (p.Glu770Asp). This variant is present in population databases (rs201711669, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PITRM1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2021 | The c.2607A>C (p.E869D) alteration is located in exon 23 (coding exon 23) of the PITRM1 gene. This alteration results from a A to C substitution at nucleotide position 2607, causing the glutamic acid (E) at amino acid position 869 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at